Gene · 92521
Papers3,158
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,701 to 1,720 of 3,158
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Could Antigen Presenting Cells Represent a Protective Element during SARS-CoV-2 Infection in Children? | Pathogens | 2021 | 33920011 | PubTator, text mining | PubMed |
| The Function of the PRRSV-Host Interactions and Their Effects on Viral Replication and Propagation in Antiviral Strategies. | Vaccines (Basel) | 2021 | 33918746 | PubTator, text mining | PubMed |
| A Perspective on COVID-19 Management. | J Clin Med | 2021 | 33918624 | PubTator, text mining | PubMed |
| Role of Structural and Non-Structural Proteins and Therapeutic Targets of SARS-CoV-2 for COVID-19. | Cells | 2021 | 33917481 | PubTator, text mining | PubMed |
| A Study of 3CLpros as Promising Targets against SARS-CoV and SARS-CoV-2. | Microorganisms | 2021 | 33916747 | PubTator, text mining | PubMed |
| Novel and emerging mutations of SARS-CoV-2: Biomedical implications. | Biomed Pharmacother | 2021 | 33915502 | PubTator, text mining | PubMed |
| Fast and efficient purification of SARS-CoV-2 RNA dependent RNA polymerase complex expressed in Escherichia coli. | PLoS One | 2021 | 33914787 | PubTator, text mining | PubMed |
| Virus Caused Imbalance of Type I IFN Responses and Inflammation in COVID-19. | Front Immunol | 2021 | 33912161 | PubTator, text mining | PubMed |
| Impact of meteorological parameters and population density on variants of SARS-CoV-2 and outcome of COVID-19 pandemic in Japan. | Epidemiol Infect | 2021 | 33908339 | PubTator, text mining | PubMed |
| SARS-CoV-2 main protease suppresses type I interferon production by preventing nuclear translocation of phosphorylated IRF3. | Int J Biol Sci | 2021 | 33907518 | PubTator, text mining | PubMed |
| The continued global battle against SARS-CoV-2 and COVID-19. | Int J Biol Sci | 2021 | 33907506 | PubTator, text mining | PubMed |
| Overcoming Culture Restriction for SARS-CoV-2 in Human Cells Facilitates the Screening of Compounds Inhibiting Viral Replication. | Antimicrob Agents Chemother | 2021 | 33903110 | PubTator, text mining | PubMed |
| Genomic and epidemiological characteristics of SARS-CoV-2 in Africa. | PLoS Negl Trop Dis | 2021 | 33901167 | PubTator, text mining | PubMed |
| Cell death pathways and viruses: Role of microRNAs. | Mol Ther Nucleic Acids | 2021 | 33898103 | PubTator, text mining | PubMed |
| Promising role of curcumin against viral diseases emphasizing COVID-19 management: A review on the mechanistic insights with reference to host-pathogen interaction and immunomodulation. | J Funct Foods | 2021 | 33897833 | PubTator, text mining | PubMed |
| RNA-induced liquid phase separation of SARS-CoV-2 nucleocapsid protein facilitates NF-κB hyper-activation and inflammation. | Signal Transduct Target Ther | 2021 | 33895773 | PubTator, text mining | PubMed |
| N-Terminal Finger Stabilizes the S1 Pocket for the Reversible Feline Drug GC376 in the SARS-CoV-2 Mpro Dimer. | J Mol Biol | 2021 | 33895266 | PubTator, text mining | PubMed |
| A cell-based assay to discover inhibitors of SARS-CoV-2 RNA dependent RNA polymerase. | Antiviral Res | 2021 | 33894278 | PubTator, text mining | PubMed |
| Structural Basis of Potential Inhibitors Targeting SARS-CoV-2 Main Protease. | Front Chem | 2021 | 33889562 | PubTator, text mining | PubMed |
| Exploring the utility of extracellular vesicles in ameliorating viral infection-associated inflammation, cytokine storm and tissue damage. | Transl Oncol | 2021 | 33887552 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/92521/papers?page=86